A glucose-insulin pharmacodynamic surface modeling validation and comparison of metabolic system models

Biomedical Signal Processing and Control

Volumn 4, Issue 4, 2009, Pages 355-363

  Chase, J Geoffrey ^a   Andreassen, Steen ^b   Pielmeier, Ulrike ^b   Hann, Christopher E ^a   McAuley, Kirsten A ^c   Mann, J I ^c  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b AALBORG UNIVERSITY   (Denmark)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Diabetes; Euglycaemic clamp; Hyperinsulinaemic clamp; Insulin sensitivity; Metabolism; Model validation; Modeling; Pharmacodynamics; Pharmacokinetics

Indexed keywords

DYNAMICS; FORECASTING; INSULIN; MEDICAL PROBLEMS; METABOLISM; MODELS; PHARMACODYNAMICS; PHARMACOKINETICS; STATISTICAL TESTS;

INSULIN SENSITIVITY; METABOLIC MODELING; METABOLIC SYSTEMS; MODEL VALIDATION; PATIENT SPECIFIC; POPULATION LEVELS; PREDICTION VALIDATION; TREND PREDICTION;

POPULATION STATISTICS;

GLUCOSE; INSULIN;

ARTICLE; COMPARATIVE STUDY; COMPUTER PREDICTION; GLYCEMIC CONTROL; HYPERGLYCEMIA; IMAGE ANALYSIS; INSULIN SENSITIVITY; MATHEMATICAL MODEL; PHARMACODYNAMICS; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TREND STUDY; VALIDATION STUDY;

EID: 70349758347     PISSN: 17468094     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bspc.2009.04.002     Document Type: Article

References (54)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab. Care 27 5 (2004) 1047-1053
2. Wild S.H., and Forouhi N.G. What is the scale of the future diabetes epidemic, and how certain are we about it?. Diabetologia (2007)
3. Hossain P., Kawar B., and El Nahas M. Obesity and diabetes in the developing world--a growing challenge. N. Engl. J. Med. 356 3 (2007) 213-215
4. ADA. Economic consequences of diabetes mellitus in the US. in 1997. American Diabetes Association. Diab. Care 21 2 (1998) 296-309
5. Nichols G.A., and Brown J.B. Higher medical care costs accompany impaired fasting glucose. Diab. Care 28 9 (2005) 2223-2229
6. Olshansky S.J., Passaro D.J., Hershow R.C., Layden J., Carnes B.A., Brody J., Hayflick L., Butler R.N., Allison D.B., and Ludwig D.S. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 352 11 (2005) 1138-1145
7. Hogan P., Dall T., and Nikolov P. Economic costs of diabetes in the US in 2002. Diab. Care 26 3 (2003) 917-932
8. ADA. The prevention or delay of type 2 diabetes. Diab. Care 25 4 (2002) 742-749
9. ADA. Standards of medical care in diabetes-2006. Diab. Care 29 (2006) S4-S42
10. Mainous A.G., Diaz V.A., Saxena S., Baker R., Everett C.J., Koopman R.J., and Majeed A. Diabetes management in the USA and England: comparative analysis of national surveys. J. R. Soc. Med. 99 9 (2006) 463-469
11. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin. Proc. 79 8 (2004) 992-1000
12. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., and Bouillon R. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345 19 (2001) 1359-1367
13. Chase J.G., Shaw G., Le Compte A., Lonergan T., Willacy M., Wong X.W., Lin J., Lotz T., Lee D., and Hann C. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit. Care 12 2 (2008) R49
14. Krinsley J. Perioperative glucose control. Curr. Opin. Anaesthesiol. 19 2 (2006) 111-116
15. Van den Berghe G., Wouters P.J., Kesteloot K., and Hilleman D.E. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit. Care Med. 34 3 (2006) 612-616
16. Krinsley J.S., and Jones R.L. Cost analysis of intensive glycemic control in critically ill adult patients. Chest 129 3 (2006) 644-650
17. Egi M., Bellomo R., Stachowski E., French C.J., and Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105 2 (2006) 244-252
18. Chase J.G., Hann C.E., Shaw G.M., Wong X.W., Lin J., Lotz T., Le Compte A.J., and Lonergan T. An overview of glycemic control in critical care-relating performance and clinical results. J. Diab. Sci. Technol. 1 1 (2007) 82-91
19. Carson E.R., and Cobelli C. Modelling Methodology for Physiology and Medicine (2001), Academic Press, San Diego
20. Arleth T., Andreassen S., Federici M.O., and Benedetti M.M. A model of the endogenous glucose balance incorporating the characteristics of glucose transporters. Comput. Methods Prog. Biomed. 62 3 (2000) 219-234
21. Hovorka R., Canonico V., Chassin L.J., Haueter U., Massi-Benedetti M., Federici M.O., Pieber T.R., Schaller H.C., Schaupp L., Vering T., et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol. Meas. 25 4 (2004) 905-920
22. Plank J., Blaha J., Cordingley J., Wilinska M.E., Chassin L.J., Morgan C., Squire S., Haluzik M., Kremen J., Svacina S., et al. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diab. Care 29 2 (2006) 271-276
23. Wong X.W., Singh-Levett I., Hollingsworth L.J., Shaw G.M., Hann C.E., Lotz T., Lin J., Wong O.S., and Chase J.G. A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diab. Technol. Ther. 8 2 (2006) 174-190
24. Wong J., Chase J.G., Hann C.E., Lotz T.F., Lin J., Le Compte A., and Shaw G.M. Development of a clinical type 1 diabetes metabolic system model and in silico simulation tool. J. Diab. Sci. Technol. 2 3 (2008) 425-435
25. Lotz T.F., Chase J.G., McAuley K.A., Lee D.S., Lin J., Hann C.E., and Mann J.I. Transient and steady-state euglycemic clamp validation of a model for glycemic control and insulin sensitivity testing. Diab. Technol. Ther. 8 3 (2006) 338-346
26. Pielmeier U., Chase J., Andreassen S., Haure P., Nielsen B., and Shaw G. Prediction Validation of Two Glycaemic Control Models in Critical Care. 17th IFAC World Congress (IFAC WC2008). Seoul, Korea, July 6-11 (2008) 8074-8079
27. McAuley K.A., Williams S.M., Mann J.I., Goulding A., Chisholm A., Wilson N., Story G., McLay R.T., Harper M.J., and Jones I.E. Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial. Diab. Care 25 3 (2002) 445-452
28. Wong X.W., Chase J.G., Shaw G.M., Hann C.E., Lotz T., Lin J., Singh-Levett I., Hollingsworth L.J., Wong O.S., and Andreassen S. Model predictive glycaemic regulation in critical illness using insulin and nutrition input: a pilot study. Med. Eng. Phys. 28 7 (2006) 665-681
29. Blakemore A., Wang S., LeCompte A., Wong X., Shaw G., Lin J., Lotz T., Hann C., and Chase J. Model-based insulin sensitivity as a sepsis diagnostic in critical care. J. Diab. Sci. Technol. (JoDST) 2 3 (2008) 468-477
30. Lotz T.F., Chase J.G., McAuley K.A., Shaw G.M., Wong X.W., Lin J., Lecompte A., Hann C.E., and Mann J.I. Monte Carlo analysis of a new model-based method for insulin sensitivity testing. Comput. Methods Prog. Biomed. 89 3 (2008) 215-225
31. Bergman R.N., Finegood D.T., and Ader M. Assessment of insulin sensitivity in vivo. Endocr. Rev. 6 1 (1985) 45-86
32. Bergman R.N., Prager R., Volund A., and Olefsky J.M. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J. Clin. Invest. 79 3 (1987) 790-800
33. Pacini G., and Bergman R.N. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput. Methods Prog. Biomed. 23 2 (1986) 113-122
34. Vicini P., Caumo A., and Cobelli C. The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity. Am. J. Physiol. 273 5 Pt 1 (1997) E1024-E1032
35. Vicini P., Caumo A., and Cobelli C. Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulation. IEEE Trans. Biomed. Eng. 46 2 (1999) 130-137
36. Dalla Man C., Caumo A., and Cobelli C. The oral glucose minimal model: Estimation of insulin sensitivity from a meal test. IEEE Trans. Biomed. Eng. 49 5 (2002) 419-429
37. Dalla Man C., Campioni M., Polonsky K.S., Basu R., Rizza R.A., Toffolo G., and Cobelli C. Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes 54 11 (2005) 3265-3273
38. Chambrier C., Laville M., Rhzioual Berrada K., Odeon M., Bouletreau P., and Beylot M. Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin. Sci. (Lond.) 99 4 (2000) 321-328
39. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237 3 (1979) E214-E223
40. Lotz T., Chase J.G., Lin J., Wong X.W., Hann C.E., McAuley K.A., and Andreassen S. Integral-based identification of a physiological insulin and glucose model on euglycaemic clamp trials. 14th IFAC Symposium on System Identification (SYSID 2006). Newcastle, Australia: IFAC, March 29-31 (2006) 463-468
41. Doran CV. Modelling and Control of Hyperglycemia in Critical Care Patients. Masters of Engineering (ME). University of Canterbury, Christchurch, New Zealand, 2004.
42. Hann C.E., Chase J.G., Lin J., Lotz T., Doran C.V., and Shaw G.M. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput. Methods Prog. Biomed. 77 3 (2005) 259-270
43. Lin J., Lee D.S., Chase J.G., Hann C.E., Lotz T., and Wong X.W. Stochastic Modelling of Insulin Sensitivity Variability in Critical Care. Biomed. Signal Process. Control 1 (2006) 229-242
44. Lin J., Lee D., Chase J.G., Shaw G.M., Le Compte A., Lotz T., Wong J., Lonergan T., and Hann C.E. Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput. Methods Prog. Biomed. 89 2 (2008) 141-152
45. Cobelli C., Caumo A., and Omenetto M. Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model. Am. J. Physiol. 277 3 Pt 1 (1999) E481-E488
46. Pacini G., and Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract. Res. Clin. Endocrinol. Metab. 17 3 (2003) 305-322
47. Prigeon R.L., Roder M.E., Porte Jr. D., and Kahn S.E. The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J. Clin. Invest. 97 2 (1996) 501-507
48. Natali A., Gastaldelli A., Camastra S., Sironi A.M., Toschi E., Masoni A., Ferrannini E., and Mari A. Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. Am. J. Physiol. Endocrinol. Metab. 278 5 (2000) E794-E801
49. Andreassen S., Pielmeier U., and Chase J. Receptor-based models of insulin saturation dynamics. The Sixth IASTED International Conference on Biomedical Engineering (BIOMED 2008). Innsbruck, Austria, February 13-15 (2008) 4 pp
50. Cobelli C., Bettini F., Caumo A., and Quon M.J. Overestimation of minimal model glucose effectiveness in presence of insulin response is due to undermodeling. Am. J. Physiol. 275 6 Pt 1 (1998) E1031-E1036
51. Toffolo G., and Cobelli C. The hot IVGTT two-compartment minimal model: an improved version. Am. J. Physiol. Endocrinol. Metab. 284 2 (2003) E317-E321
52. Hovorka R., Shojaee-Moradie F., Carroll P.V., Chassin L.J., Gowrie I.J., Jackson N.C., Tudor R.S., Umpleby A.M., and Jones R.H. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am. J. Physiol. Endocrinol. Metab. 282 5 (2002) E992-E1007
53. Hovorka R., Chassin L.J., and Wilinska M.E. Virtual type 1 diabetic treated by CSII: Model description. WC2003. Sydney, Australia, 24-29 August (2003)
54. Toffolo G., De Grandi F., and Cobelli C. Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion. Diabetes 44 7 (1995) 845-854